Article Information
History
- April 25, 2020.
Article Versions
- Version 1 (October 27, 2019 - 16:29).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Fabio Zanini1,2,+,*,
- Bojk A. Berghuis1,+,
- Robert C. Jones1,
- Benedetta Nicolis di Robilant3,
- Rachel Yuan Nong1,4,
- Jeffrey Norton5,
- Michael F. Clarke3 and
- Stephen R. Quake1,6,7,*
- 1Department of Bioengineering, Stanford University, Stanford, CA, USA
- 2Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
- 3Department of Oncology, Stanford School of Medicine, Stanford, CA, USA
- 4Department of Immunology, Genetics and Pathology and SciLifeLab, Uppsala University, Uppsala, Sweden
- 5Department of Surgery - Stanford Pancreas Cancer Research Group, General Surgery, Stanford University School of Medicine, Stanford, CA, USA
- 6Department of Applied Physics, Stanford University, Stanford, CA, USA
- 7Chan Zuckerberg Biohub, San Francisco, CA, USA
- ↵*to whom correspondence should be addressed: fabio.zanini{at}unsw.edu.au, quake{at}stanford.edu
↵+ these authors contributed equally
Posted April 25, 2020.
Northstar enables automatic classification of known and novel cell types from tumor samples
